The real test for healthtech companies isn’t innovation – it’s implementation

After years of buzz around AI, digital therapeutics, and TechBio, the conversation in pharma is changing. The key question now isn’t what’s possible—it’s what can actually be integrated into real workflows, systems, and governance across healthcare and pharma.

The article points to Switzerland’s Basel region as a live example of this shift, where life sciences, computing, and healthtech are converging—and collaborations are becoming more structured, measurable, and deployment-focused. It also highlights how companies and start-ups are being pushed to move beyond pilots, prioritising interoperability, cybersecurity, validation, and clear operational value, especially in areas like clinical development where better execution can have an outsized impact.

Read the full article on the original source (pharmaphorum).